For years, the standard medical advice to treat obesity was to eat less and to exercise more. But new drugs like Ozempic and Wegovy have

(MedPage Today) — Weight-loss injectables for pets? Okava Pharmaceuticals announced plans to kick off a pilot study of a GLP-1 drug for cats with obesity.

Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer”s trials (www.reuters.com) 04:42  

The World Health Organization (WHO) has announced its official guidance on the use of GLP-1 drugs for treating obesity. GLP-1 drugs are medications that mimic

Despite a lack of results from the trials, the Vice President of the company says “we still think it was the right decision.”

In tonight’s edition, a month after losing his jon a chief of defence staff amidst coup concerns, nigerian General Christopher Musa returns to government as

The World Health Organization is backing GLP-1 medications for the treatment of obesity, which some advocates hope will open up access to the drugs and

New research offers a rare glimpse into how popular weight-loss medications affect electrical activity deep within the human brain. A case study involving a patient

The WHO recommended GLP-1s as a treatment for obesity alongside a healthy diet and regular exercise. Milles Team/Stocksy New guidelines from the World Health Organization

Enteroendocrine cells (EECs) are the principal nutrient sensors in the gastrointestinal (GI) tract and release hormones such as glucagon-like-peptide 1 (GLP-1) that modulate GI function

Trump’s deal with drug manufacturers lowering the cost of GLP-1s will expand coverage for many patients. Caroline Messer, MD, explains why she welcomes this deal.

Amy Schumer went from a hustling stand-up comedian to a major movie star. “After my dad got MS and we went bankrupt and my mom

WHO guidelines say GLP-1 drugs are effective as long-term treatment for obesity in adults, barring pregnant women, alongside diet, exercise interventions; call for equitable access

TUESDAY, Dec. 2, 2025 — Long-term glucagon-like peptide-1 (GLP-1) therapies combined with intensive behavioral therapy are recommended for adults with obesity, according to a special

Wall Street recorded a subdued November this year. The S&P 500 lost 0.04% over the past month (as of Nov. 28, 2025), the Dow Jones

Quick Read Wells Fargo just raised its price target on Amazon to $295 a share, with an overweight rating. Analysts at Bank of America reiterated

In a first, the World Health Organization has issued a guideline on GLP-1s, a drug class that up to 1 in 8 U.S. adults report

By I. Edwards HealthDay ReporterTUESDAY, Dec. 2, 2025 (HealthDay News) — The World Health Organization (WHO) released its first-ever guideline on…

Glucagon-like peptide-1 receptor (GLP-1R) activation in the brain strongly reduces appetite, but most brain GLP-1Rs are not accessible for systemically administered GLP-1R agonists. Acute activation

The guideline reframes obesity as a chronic disease needing lifelong care, recommending GLP-1 therapies with behavioural support rather than relying on medication alone

Nature, Published online: 02 December 2025; doi:10.1038/d41586-025-03911-x Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as

GLP-1 drugs for pets could be the next frontier for the blockbuster weight loss and diabetes drugs.

Breakthroughs in weight-loss medicine are presenting state Medicaid officials with what looks like a sure bet: Spend big now to cover the drugs and reap

Nutrients, Vol. 17, Pages 3778: Consuming Tree Nuts Daily as Between-Meal Snacks Reduces Food Cravings and Improves Diet Quality in American Young Adults at High

Obesities, Vol. 5, Pages 88: Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review Obesities doi: 10.3390/obesities5040088 Authors: Denise Deo Dias Andrea

Metropolis Healthcare has rolled out three TruHealth GLP-1 test packages for patients preparing for or undergoing obesity treatment, as diagnostics firms move to tap the

Post Content

A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for

WHO has issued its first guidelines recommending GLP-1 drugs for long-term obesity treatment in adults, while stressing equitable access, health system readiness and lifestyle support

<p>To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO) has released its <a href=”https://app.magicapp.org/#/guideline/LrRxrL”>first

Dual therapy with metformin and GLP-1 RAs is associated with a lower risk for adiposity-related cancers and mortality than DPP-4 inhibitor therapy in patients with

To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO) has released its first

The World Health Organisation has released guidelines recommending GLP-1-type medications as long-term treatments for obesity, issuing a global call to its member states to ensure

GLP-1 therapies are a class of medicines that help lower blood sugar, support weight loss, reduce the risk of heart and kidney complications, and can

Grounded in emerging research, Danone’s research and innovation team is developing nutrient-dense products tailored to every stage of the GLP-1 user journey – and meeting

The federal government negotiated with drug makers to bring lower prices on GLP-1 drugs to millions of Medicare patients. Medscape Medical News

It’s been a volatile year in stock markets around the world. From tariff scares through to monetary policy shifts, investors have been left trying to

In September, the WHO added GLP-1 therapies to its Essential Medicines List for managing Type 2 diabetes in high-risk groups.

India’s GLP-1 Moment Could Reshape Sugar Market  czapp.com